AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 27th, 2009 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), made this 6th day of November 2008, is entered into by Sepracor Inc., a Delaware corporation with its principal place of business at 84 Waterford Drive, Marlborough, Massachusetts 01752-7231 (the “Company”), and Mark Iwicki residing at 12 Bristol Terrace, Long Valley, New Jersey 07853 (the “Executive”).
SEPRACOR INC. Executive Retention AgreementExecutive Retention Agreement • February 27th, 2009 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT by and between Sepracor Inc., a Delaware corporation (the “Company”), and (the “Executive”) is made as (the “Effective Date”).
SEPRACOR INC. Executive Retention AgreementExecutive Retention Agreement • February 27th, 2009 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT by and between Sepracor Inc., a Delaware corporation (the “Company”), and (the “Executive”) is made as of February 1, 2002 (the “Effective Date”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 27th, 2009 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), made this 6th day of November 2008 (the “Effective Date”), is entered into by Sepracor Inc., a Delaware corporation with its principal place of business at 84 Waterford Drive, Marlborough, Massachusetts 01752-7231(the “Company”), and Mark H. N. Corrigan, residing at 389 Marlborough Street, Boston, MA 02115 (the “Executive”).
AMENDMENT TO DECEMBER 5, 1997 EXCLUSIVE LICENSE AGREEMENT BETWEEN SCHERING AND SEPRACORExclusive License Agreement • February 27th, 2009 • Sepracor Inc /De/ • Pharmaceutical preparations
Contract Type FiledFebruary 27th, 2009 Company IndustryThis amendment to the December 5, 1997 Exclusive License Agreement between Schering and Sepracor (“the Amendment”) is made as of this 7th day of November, 2008 by Schering-Plough Ltd., a Swiss corporation having a place of business at Topferstrasse 5, 6004 Lucerne, Switzerland (“Schering”), and Sepracor Inc., a Delaware corporation having a place of business at 84 Waterford Drive, Marlborough, Massachusetts 01752 (“Sepracor”) (collectively, “the Parties”).